Filter
496
Text search:
pharmaceutical
policies
Featured
Recommendations
47
New Publications
123
Language
Document type
No document type
245
Studies & Reports
115
Guidelines
72
Strategic & Response Plan
29
Manuals
15
Training Material
6
Situation Updates
4
Fact sheets
4
Brochures
3
Resource Platforms
3
Countries / Regions
Ethiopia
30
Kenya
28
Global
20
India
15
Western and Central Europe
14
South Africa
12
Nigeria
11
Uganda
10
Rwanda
10
Ghana
9
Malawi
9
Sierra Leone
8
Zambia
8
Africa
8
Eastern Europe
8
Zimbabwe
7
Tanzania
7
Liberia
6
Philippines
6
Senegal
5
Syria
5
Namibia
5
Nepal
4
Bangladesh
4
Ukraine
4
South–East Asia Region
4
Congo, Democratic Republic of
3
Cameroon
3
South Sudan
2
Indonesia
2
Sudan
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Albania
2
Mali
1
Niger
1
Haiti
1
Pakistan
1
Jordan
1
Germany
1
Chad
1
Cambodia
1
Thailand
1
Mozambique
1
Papua New Guinea
1
Benin
1
Eswatini/ Swaziland
1
Brazil
1
North Macedonia
1
Botswana
1
Chile
1
Western Pacific Region
1
Latin America and the Carribbean
1
Asia
1
Fiji
1
Venezuela
1
Timor Leste/ East Timor
1
Lithuania
1
Iran
1
Vietnam
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
223
Key Resources
25
Clinical Guidelines
24
Public Health
21
Women & Child Health
11
Pharmacy & Technologies
8
Capacity Building
3
Toolboxes
AMR
58
COVID-19
51
Pharmacy
35
TB
30
HIV
27
Mental Health
24
NTDs
12
Rapid Response
11
NCDs
11
Global Health Education
9
Caregiver
9
Planetary Health
9
Health Financing Toolbox
7
Conflict
6
Disability
4
Ebola & Marburg
4
2.0 Rapid Response
4
Zika
3
Refugee
2
Specific Hazards
2
Cholera
1
Polio
1
Natural Hazards
1
Malaria
1
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting,
...
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Version 2 (unedited). The Basic Needs Analysis (BNA) is a multi-sector needs analysis approach that can be applied in both sudden onset and protracted emergencies. The methodology comprises the Guidance (this document) presenting the conceptual BNA framework and related processes, and a Toolbox, whi
...
The 10 recommendations in the COP26 Special Report on Climate Change and Health propose a set of priority actions from the global health community to governments and policy makers, calling on them to act with urgency on the current climate and health crises.
The recommendations were developed in
...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan
...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a
...
Zika Virus Infection - Step-by-Step Guide to Risk Communication and Community Engagement
recommended
This document provides Technical content on ZIKV, its manifestations, complications, modes of transmission, and prevention measures to be used in answering frequently asked questions and conveying messages in information and communication materials, community talks, press conferences, etc.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
WHO Secretariat Information paper July 2016
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
